Anxiety in African-American Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an African-American Sample - Full Text View

Sponsors and Collaborators:	Memorial Sloan-Kettering Cancer Center VA New York Harbor Healthcare System University School of Medicine(VA-NYU) Queens Cancer Center -New York State University of New York - Downstate Medical Center Kings County Hospital Center
Information provided by:	Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier:	NCT00581672

Purpose

This study is being done to see if a standard tool used to check anxiety in white men works well for African American men. The tool is used only for men who have prostate cancer. It is meant to see how the cancer affects men. If we have a good tool, it is more likely that we can help those who have high levels of anxiety. This test is known as the Memorial Anxiety Scale for Prostate Cancer (also called the MAX-PC).

Condition	Intervention
Prostate Cancer	Behavioral: questionnaires of quality of life

MedlinePlus related topics: Anxiety Cancer Prostate Cancer

U.S. FDA Resources

Study Type:	Observational
Study Design:	Cohort, Prospective
Official Title:	Anxiety in African-American Men With Prostate Cancer: Validation of the Memorial Anxiety Scale for Prostate Cancer in an African-American Sample

Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:

To establish the psychometric properties of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) in African-American men with prostate cancer. [ Time Frame: within one to three weeks of receiving their PSA scores from their physician ] [ Designated as safety issue: No ]

Secondary Outcome Measures:

To explore the prevalence of distress, anxiety, and depression in African-American men with prostate cancer. [ Time Frame: within one to three weeks of receiving their PSA scores from their physician ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	150
Study Start Date:	September 2007
Estimated Study Completion Date:	December 2010
Estimated Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
questionnaires 150 African-American men with prostate cancer	Behavioral: questionnaires of quality of life Subjects will be asked to complete the MAX-PC along with additional psychosocial questionnaires which include anxiety, depression and quality of life measures and will take approximately one 30 minutes to complete by patient.

Detailed Description:

This study is being done to see if a standard tool used to check anxiety in white men works well for African American men. The tool is used only for men who have prostate cancer. It is meant to see how the cancer affects men. If we have a good tool, it is more likely that we can help those who have high levels of anxiety. This test is known as the Memorial Anxiety Scale for Prostate Cancer (also called the MAX-PC).

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No
Sampling Method:	Probability Sample

Study Population

African-American men with prostate cancer

Criteria

Inclusion Criteria:

18 years of age or older
Patients who are being monitored by PSA tests, who will have a PSA test done on the day of their current clinic visit or prior to their clinic visit, but prior to being informed of the results
Diagnosis of prostate cancer
Ethnicity: Black, African-American, or of African descent (and will include those men who identify as Black and Hispanic).
Ability to comprehend and complete questionnaires in English

Exclusion Criteria:

Major psychopathology or cognitive impairment likely, in the judgment of the research staff, to interfere with the participation or completion of the protocol
Other non-Black or non-African-American ethnic groups

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00581672

Contacts

Contact: Christian Nelson, PhD

nelsonc@mskcc.org

Locations

United States, New York
Memorial Sloan-Kettering Cancer Center	Recruiting
New York, New York, United States, 10065
Contact: Christian Nelson, PhD nelsonc@mskcc.org
Downstate Medical Center	Recruiting
Brooklyn, New York, United States, 11203
Contact: Christian Nelson, PhD nelsonc@mskcc.org
Queens Hospital Center	Recruiting
Jamaica, New York, United States, 11432
Contact: Christian Nelson, PhD
VA Medical Center Manhattan	Recruiting
New York, New York, United States, 10010
Contact: Christian Nelson, PhD

Sponsors and Collaborators

Memorial Sloan-Kettering Cancer Center

VA New York Harbor Healthcare System

University School of Medicine(VA-NYU)

Queens Cancer Center -New York

State University of New York - Downstate Medical Center

Kings County Hospital Center

Investigators

Principal Investigator:

Christian Nelson, PhD

Memorial Sloan-Kettering Cancer Center

More Information

Additional Information:

Memorial Sloan-Kettering Web Site This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party:	Memorial Sloan-Kettering Cancer Center ( Christian Nelson, PhD )
Study ID Numbers:	07-125
Study First Received:	December 21, 2007
Last Updated:	April 2, 2009
ClinicalTrials.gov Identifier:	NCT00581672 History of Changes
Health Authority:	United States: Institutional Review Board

Keywords provided by Memorial Sloan-Kettering Cancer Center:

Anxiety
African-American
Prostate Cancer

Study placed in the following topic categories:

Prostatic Diseases
Genital Neoplasms, Male
Urogenital Neoplasms
Genital Diseases, Male
Prostatic Neoplasms

Additional relevant MeSH terms:

Neoplasms
Neoplasms by Site
Prostatic Diseases
Genital Neoplasms, Male

Urogenital Neoplasms
Genital Diseases, Male
Prostatic Neoplasms

ClinicalTrials.gov processed this record on May 07, 2009